Bacteria in dental biofilm cause 95% of the oral diseases. Lumoral® is a light-activated antibacterial solution for oral health and biofilm management, for the patient's use at home. Lumoral has been clinically proven in randomised trials to treat and prevent oral diseases.
Orthodontics, such as braces or clear aligners, are hard to clean due to their complex structure and the wires, brackets, or aligner attachments that can provide a favorable environment for bacterial growth, making plaque control challenging.
As a result, residual plaque can build up, leading to potential problems like tooth decay, bad breath, gingivitis, even an onset of periodontal disease. Maintaining good oral hygiene, including regular brushing and flossing, is essential to prevent the accumulation of plaque and maintain healthy teeth and gums while undergoing orthodontic treatment.
Antibacterial treatment during orthodontic treatment can reduce the risk of infection and inflammation caused by bacteria. This is particularly important for patients who wear orthodontic appliances such as braces, which can create areas where bacteria can accumulate and grow.
Lumoral antibacterial treatment eliminates plaque from the tooth structure and around the orthodontic device, maintaining oral health and preventing the development of dental problems.
The treatment targets the tooth surface and gum line without affecting the normal bacterial balance in the mouth. Successful plaque control promotes a healthier and more comfortable orthodontic treatment experience.
Nikinmaa S, et al. (2020) Dual-light photodynamic therapy administered daily provides a sustained antibacterial effect on biofilm and prevents Streptococcus mutans adaptation. PLOS ONE 15(5): e0232775. https://doi.org/10.1371/journal.pone.0232775
Nikinmaa S, et al. (2021) Indocyanine Green-Assisted and LED-Light-Activated Antibacterial Photodynamic Therapy Reduces Dental Plaque. Dentistry Journal. 2021; 9(5):52. https://doi.org/10.3390/dj9050052
Pakarinen S, et al. Home-Applied Dual-Light Photodynamic Therapy in the Treatment of Stable Chronic Periodontitis (HOPE-CP)—Three-Month Interim Results. Dentistry Journal. 2022; 10(11):206. https://doi.org/10.3390/dj10110206
CLEAN-BRACKET
• Jansåker, Elses, et al.
• Lund, Sweden
• 20+20 patients
• Sponsored, prospective, randomized
DPS-01 (Dental Plaque study)
• Heikkinen, Uutela, et al.
• Tampere, Finland
• 20+20 patients
• Sponsored, prospective, randomized
Control Every: 12 months
✓ Mild gingivitis
✓ Prevention of bacterial dental diseases
✓ Moderate risk for caries
✓ Moderate tartar formation
✓ Bad breath
Periodontitis treatment: patients with stable treatment results and without additional risk factors.
Control Every: 3 months
✓ High caries risk
✓ Moderate gingivitis
✓ Severe tartar formation
✓ Periodontitis stage 1-2
✓ aMMP-8 above 20 ng / ml
Periodontitis treatment: patients with additional risk factors such as diabetes mellitus, cardio-vascular disease or smoking, long-term therapy is recommended.
Control Every: 1 months
✓ Severe gingivitis
✓ Periodontitis stage 3-4
✓ aMMP-8 significantly elevated
With intensive therapy, the light activation can be increased to up to 30 minutes for every Lumorinse dose. (Longer treatment time increases the antibacterial effect).
EUROPE AND OTHER MARKET AREAS
Tero Pasanen – CCO
tero.pasanen(at)koitehealth.com
+358 40 045 9080
SOUTHERN FINLAND
Riikka Nisula – Lumoral Area Manager
riikka.nisula(at)koitehealth.com
+358 40 753 3214
CENTRAL AND NORTHERN FINLAND
Emilia Kataja – Lumoral Area Manager
emilia.kataja(at)koitehealth.com
+358 40 518 5488
STOCKHOLM AREA + SWEDEN
Helen Huttunen – Country Manager
helen.huttunen(at)koitehealth.com
+46 73 560 0092